Mandate

Vinge acts for SUSI Partners on its acquisition of the Lyngsåsa wind park

September 09, 2019 M&A Energy

Vinge has acted for SUSI Partners, manager of the SUSI Renewable Energy Fund II, in connection with its acquisition of the Lyngsåsa wind park in Alvesta municipality.

As part of the transaction, SUSI Partners has secured a long-term fixed price Power Purchase Agreement (PPA) and arranged for debt financing with Hamburg Commercial Bank for the project.

The Lyngsåsa wind park will consist of 22 Vestas V150 turbines with a total capacity of 94.6 MW. The project has been developed from greenfield by BayWa r.e., with operations scheduled to begin in 2021. BayWa will also manage the complete engineering, procurement and construction (EPC) of the turnkey project. Annual production will be around 315GWh, providing electricity to the equivalent of 80,000 households, while saving approximately 93,000 tons of CO2 emissions each year.

Vinge’s team was headed by M&A partner Peter Sundgren and included e.g. partners Christoffer Thalin (M&A), Johan Cederblad (permits), Thomas Sjöberg (permits), Assur Badur (real estate), Matthias Pannier (M&A), Robert Deli (real estate); counsel Sofia Törnroth Nyberg (project financing), Maria Schultzberg (tax), Fredrik Christiansson (project financing); and associates Jack Bengtsson (project financing), Axel Jansson (project financing), Hampus Olsson (real estate), Karolina Cohrs (real estate), Vilhelm Rondahl (M&A) and Rasmus Perdahl (M&A).

Related

Vinge has advised Eleda in connection with Eleda Norge AS’s acquisition of Nettpartner Bane AS

Vinge, together with Advokatfirmaet Thommessen, has advised Eleda in connection with Eleda Norge AS’s acquisition of Nettpartner Bane AS from Å Energi owned Nettpartner AS.
January 19, 2026

Vinge advises KEYTO Group in connection with the acquisition of Smartify

KEYTO Group continues its growth journey by strengthening its offering in Sweden as Smartify Sverige AB joins KEYTO Group.
January 19, 2026

Vinge has advised Orexo in connection with the divestment of the US rights to Zubsolv

Vinge has advised Orexo in relation to Swedish law in connection with the divestment of the US rights to Zubsolv to Dexcel Pharma USA.
January 14, 2026